Table 2.

Unadjusted and adjusted models for overall mortality (using data from CRF)

Variable	AutoHCT (n = 7888)		Adult alloHCT (n = 16 558)		Pediatric alloHCT (n = 1820)
	Unadjusted HR (95% CI); P value	Adjusted HR∗ (95% CI); P value	Unadjusted HR (95% CI); P value	Adjusted HR† (95% CI); P value	Unadjusted HR (95% CI); P value	Adjusted HR‡ (95% CI); P value
Race
NHWs	1.00	1.00	1.00	1.00	1.00	1.00
NHAAs	0.85 (0.76-0.95); .004	0.91 (0.81-1.03); .12	1.12 (1.03-1.21); .005	1.13 (1.04-1.22); .004	1.76 (1.4-2.2); <.001	1.62 (1.3-2.03); <.001
Hispanics	0.93 (0.77-1.11); .41	1.04 (0.87-1.25); .66	0.91 (0.84-0.99); .03	1.01 (0.92-1.1); .89	1.22 (1.02-1.46); .03	1.17 (0.97-1.41); .10
Others	0.81 (0.64-1.030); .09	0.83 (0.65-1.05); .13	0.91 (0.82-1.01); .08	0.97 (0.87-1.07); .50	1.52 (1.15-2.02); .004	1.47 (1.11-1.96); .008
Year of transplant
2009-2010	1.00	1.00	1.00	1.00	1.00	1.00
2011-2012	0.78 (0.68-0.9); .0006	0.89 (0.77-1.03); .13	1.01 (0.94-1.08); .84	0.91 (0.85-0.98); .014	1.00 (0.79-1.26); .99	1.05 (0.83-1.32); .71
2013-2014	0.77 (0.67-0.87); <.001	0.78 (0.69-0.9); .0004	0.93 (0.87-0.99); .015	0.81 (0.76-0.86); <.001	0.77 (0.63-0.94); .01	0.75 (0.6-0.93); .008
2015-2016	0.75 (0.65-0.86); <.001	0.72 (0.62-0.83); <.001	0.91 (0.85-0.97); .003	0.78 (0.73-0.83); <.001	0.56 (0.44-0.7); <.001	0.53 (0.42-0.68); <.001
2017-2018	0.60 (0.5-0.72); <.001	0.60 (0.5-0.72); <.001	0.75 (0.7-0.81); <.001	0.66 (0.61-0.71); <.001	0.74 (0.57-0.96); .03	0.71 (0.54-0.92); .01

CI, confidence interval; HR, hazard ratio.

^∗Other significant variables include patient age, sex, diagnosis, disease status, HCT-CI, KPS, and marital status.

^†Other significant variables include patient age, diagnosis, disease risk, HCT-CI, KPS, insurance, and donor type.

^‡Other significant variables include disease status at HCT, HCT-CI, and recipient cytomegalovirus status.